ReviewCancer

The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise

See allHide authors and affiliations

Science Translational Medicine  05 Jan 2011:
Vol. 3, Issue 64, pp. 64rv1
DOI: 10.1126/scitranslmed.3001366

Log in to view full text


Navigate This Article